These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33968071)

  • 1. BTLA Expression and Function Are Impaired on SLE B Cells.
    Wiedemann A; Lettau M; Weißenberg SY; Stefanski AL; Schrezenmeier EV; Rincon-Arevalo H; Reiter K; Alexander T; Hiepe F; Lino AC; Dörner T
    Front Immunol; 2021; 12():667991. PubMed ID: 33968071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
    Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
    Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
    Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
    Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B- and T-Lymphocyte Attenuator in Systemic Lupus Erythematosus Disease Pathogenesis.
    Vendel AC; Jaroszewski L; Linnik MD; Godzik A
    Clin Pharmacol Ther; 2024 Jul; 116(1):247-256. PubMed ID: 38676311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
    Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.
    Colombo BM; Canevali P; Magnani O; Rossi E; Puppo F; Zocchi MR; Poggi A
    PLoS One; 2012; 7(2):e31903. PubMed ID: 22355402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.
    Sawaf M; Fauny JD; Felten R; Sagez F; Gottenberg JE; Dumortier H; Monneaux F
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell subsets, signaling and their roles in secretion of autoantibodies.
    Iwata S; Tanaka Y
    Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.
    Oster C; Wilde B; Specker C; Sun M; Kribben A; Witzke O; Dolff S
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
    Dörner T; Szelinski F; Lino AC; Lipsky PE
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32675278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
    Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
    Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients.
    Rodríguez-Bayona B; Ramos-Amaya A; Pérez-Venegas JJ; Rodríguez C; Brieva JA
    Arthritis Res Ther; 2010; 12(3):R108. PubMed ID: 20525218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Reprogramming Commits Differentiation of Human CD27
    Torigoe M; Iwata S; Nakayamada S; Sakata K; Zhang M; Hajime M; Miyazaki Y; Narisawa M; Ishii K; Shibata H; Tanaka Y
    J Immunol; 2017 Jul; 199(2):425-434. PubMed ID: 28626065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex.
    Axelsson S; Magnuson A; Lange A; Alshamari A; Hörnquist EH; Hultgren O
    BMC Immunol; 2020 Mar; 21(1):14. PubMed ID: 32197584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
    Aubergeon L; Sawaf M; Felten R; Gottenberg JE; Dumortier H; Monneaux F
    Front Immunol; 2021; 12():767099. PubMed ID: 34899718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.